Gene · 6573
Papers1,999
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,999
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pre-autism: What a paediatrician should know about early diagnosis of autism. | World J Clin Pediatr | 2023 | 38178935 | PubTator, text mining | PubMed |
| Discovery of Tumor-Targeted 6-Methyl Substituted Pemetrexed and Related Antifolates with Selective Loss of RFC Transport. | ACS Med Chem Lett | 2023 | 38116433 | PubTator, text mining | PubMed |
| Methotrexate and cardiovascular prevention: an appraisal of the current evidence. | Ther Adv Cardiovasc Dis | 2023 | 38115784 | PubTator, text mining | PubMed |
| Thiamin (Vitamin B1) - A scoping review for Nordic Nutrition Recommendations 2023. | Food Nutr Res | 2023 | 38084159 | PubTator, text mining | PubMed |
| Efficient delivery of methotrexate to MDA-MB-231 breast cancer cells by a pH-responsive ZnO nanocarrier. | Sci Rep | 2023 | 38081993 | PubTator, text mining | PubMed |
| Single-nucleotide polymorphism profiling by multimodal-targeted next-generation sequencing in methotrexate-resistant and -sensitive human osteosarcoma cell lines. | Front Pharmacol | 2023 | 38074116 | PubTator, text mining | PubMed |
| Recent Advances in Folates and Autoantibodies against Folate Receptors in Early Pregnancy and Miscarriage. | Nutrients | 2023 | 38068740 | PubTator, text mining | PubMed |
| Gene mutation analysis of oral submucous fibrosis cancerization in Hainan Island. | PeerJ | 2023 | 38050610 | PubTator, text mining | PubMed |
| EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas. | Front Immunol | 2023 | 38035116 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications. | Elife | 2023 | 37995198 | PubTator, text mining | PubMed |
| Molecular dynamics of JUNO-IZUMO1 complexation suggests biologically relevant mechanisms in fertilization. | Sci Rep | 2023 | 37990051 | PubTator, text mining | PubMed |
| Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia. | Hematol Rep | 2023 | 37987321 | PubTator, text mining | PubMed |
| Exosomal miR-200c and miR-141 as cerebrospinal fluid biopsy biomarkers for the response to chemotherapy in primary central nervous system lymphoma. | Discov Oncol | 2023 | 37971595 | PubTator, text mining | PubMed |
| Pafolacianine, the magic wand of intraoperative imaging of folate-receptor positive ovarian cancer. | Ann Transl Med | 2023 | 37970599 | PubTator, text mining | PubMed |
| Understanding the feasibility of chemotherapeutic and immunotherapeutic targets against non-small cell lung cancers: an update of resistant responses and recent combinatorial therapies. | Explor Target Antitumor Ther | 2023 | 37970206 | PubTator, text mining | PubMed |
| Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients. | Front Oncol | 2023 | 37965460 | PubTator, text mining | PubMed |
| Scientific opinion on the tolerable upper intake level for folate. | EFSA J | 2023 | 37965303 | PubTator, text mining | PubMed |
| Uncovering the Hidden Dangers and Molecular Mechanisms of Excess Folate: A Narrative Review. | Nutrients | 2023 | 37960352 | PubTator, text mining | PubMed |
| Regulatory mechanisms of one-carbon metabolism enzymes. | J Biol Chem | 2023 | 37949226 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6573/papers?page=6